Mitoxantrone in multiple sclerosis

Adv Neurol. 2006:98:293-302.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / pharmacology
  • Antineoplastic Agents / therapeutic use
  • Clinical Trials as Topic / statistics & numerical data
  • Encephalomyelitis, Autoimmune, Experimental / drug therapy
  • Encephalomyelitis, Autoimmune, Experimental / immunology
  • Encephalomyelitis, Autoimmune, Experimental / physiopathology
  • Humans
  • Immune System / drug effects
  • Immune System / immunology
  • Immunologic Factors / adverse effects
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use
  • Mitoxantrone / adverse effects
  • Mitoxantrone / pharmacology*
  • Mitoxantrone / therapeutic use*
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / physiopathology
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Immunologic Factors
  • Mitoxantrone